DK4247334T3 - Farmaceutisk sammensætning til anvendelse til forebyggelse eller behandling af en tilstand, der er forbundet med en reduktion i antallet af lactobacilli i vagina - Google Patents

Farmaceutisk sammensætning til anvendelse til forebyggelse eller behandling af en tilstand, der er forbundet med en reduktion i antallet af lactobacilli i vagina Download PDF

Info

Publication number
DK4247334T3
DK4247334T3 DK21815631.3T DK21815631T DK4247334T3 DK 4247334 T3 DK4247334 T3 DK 4247334T3 DK 21815631 T DK21815631 T DK 21815631T DK 4247334 T3 DK4247334 T3 DK 4247334T3
Authority
DK
Denmark
Prior art keywords
lactobacilli
vagina
treating
preventing
reduction
Prior art date
Application number
DK21815631.3T
Other languages
English (en)
Inventor
Alastair Sutcliffe
Catherine Tuleu
Paul Long
Original Assignee
Ucl Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucl Business Ltd filed Critical Ucl Business Ltd
Application granted granted Critical
Publication of DK4247334T3 publication Critical patent/DK4247334T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK21815631.3T 2020-11-17 2021-11-17 Farmaceutisk sammensætning til anvendelse til forebyggelse eller behandling af en tilstand, der er forbundet med en reduktion i antallet af lactobacilli i vagina DK4247334T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2018068.3A GB202018068D0 (en) 2020-11-17 2020-11-17 Pharmaceutical composition
PCT/GB2021/052973 WO2022106819A2 (en) 2020-11-17 2021-11-17 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK4247334T3 true DK4247334T3 (da) 2024-12-16

Family

ID=74046636

Family Applications (1)

Application Number Title Priority Date Filing Date
DK21815631.3T DK4247334T3 (da) 2020-11-17 2021-11-17 Farmaceutisk sammensætning til anvendelse til forebyggelse eller behandling af en tilstand, der er forbundet med en reduktion i antallet af lactobacilli i vagina

Country Status (11)

Country Link
US (1) US20240122962A1 (da)
EP (1) EP4247334B1 (da)
JP (1) JP2023549260A (da)
KR (1) KR20230110536A (da)
CN (1) CN116897042A (da)
AU (1) AU2021384002A1 (da)
CA (1) CA3198250A1 (da)
DK (1) DK4247334T3 (da)
ES (1) ES3003133T3 (da)
GB (1) GB202018068D0 (da)
WO (1) WO2022106819A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202300026142A1 (it) * 2023-12-06 2025-06-06 Fidia Farm Spa Composizioni mucoadesive per il trattamento locale delle affezioni vaginali

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160719A (en) * 1979-06-01 1980-12-13 Sankyo Co Ltd Remedy for microbial infectious disease
JPH0421633A (ja) * 1990-05-17 1992-01-24 Saikon Medics:Kk 生体下口腔内有用微生物叢の維持管理法および維持管理組成物
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
AU1223099A (en) 1997-11-24 1999-06-15 Zhongming Zeng Pharmaceutical formulation for stimulating the growth of gram-positive bacil li and increasing the acidity in vagina and the use thereof
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
EP1911454B1 (en) * 2005-04-27 2012-01-11 Shenzhen Phlora Biotechnology Limited A composition and method of regulating and maintaining the vaginal bacterial flora and the normal acidity in the vagina
EP2130531A1 (en) * 2008-06-04 2009-12-09 Rolf Kullgren AB Vaginal suppository comprising lactic acid
CN108452293A (zh) * 2018-04-12 2018-08-28 广西达庆生物科技有限公司 一种妇科用凝胶及其制备方法

Also Published As

Publication number Publication date
CA3198250A1 (en) 2022-05-27
CN116897042A (zh) 2023-10-17
EP4247334B1 (en) 2024-10-09
KR20230110536A (ko) 2023-07-24
JP2023549260A (ja) 2023-11-22
AU2021384002A1 (en) 2023-06-22
US20240122962A1 (en) 2024-04-18
WO2022106819A3 (en) 2022-07-07
AU2021384002A9 (en) 2024-05-02
GB202018068D0 (en) 2020-12-30
ES3003133T3 (en) 2025-03-10
EP4247334A2 (en) 2023-09-27
WO2022106819A2 (en) 2022-05-27

Similar Documents

Publication Publication Date Title
IL289975A (en) Use of cannabidiol in the treatment of dravet syndrome
DK3658539T3 (da) Forbindelser og sammensætninger til behandling af tilstande, som er forbundet med nlrp-aktivitet
DK3883579T3 (da) Kombinationsterapi, der omfatter en kras-g12c-inhibitor og et eller flere yderligere farmaceutisk aktive stoffer, til behandling af cancer
DOP2018000182A (es) Benzamidas sustituidas con 1,3–tiazol–2–ilo
SG10201908697XA (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
MX2023000796A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
CL2013001339A1 (es) Compuestos derivados heterociclicos condensados, con actividad antiviral; composicion farmaceutica que los comprende; y su uso para la prevencion o tratamiento de la infeccion de vih.
SG11201811697SA (en) Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof
DK3362449T3 (da) Sibirilin-derivater til anvendelse til at forebygge og/eller behandle lidelser associeret med cellulær nekroptose
CL2014000801A1 (es) Variante de factor 21 de crecimiento de fibroblasto humano (fgf21); composicion farmaceutica que lo comprende; y su uso para tratar diabetes tipo 2, obesidad, dislipidemia, sindrome metabolico o cualquier combinacion de los mismos.
MX381599B (es) Empagliflozina para usarse en el tratamiento de micro y macroalbuminuria
DK3746126T3 (da) Fremgangsmåder og sammensætninger til behandling af søvnapnø eller simpel snorken
MX2021003905A (es) Composicion de liberacion modificada de orlistat y acarbosa para el tratamiento de la obesidad y trastornos metabolicos relacionados.
BR112018069515A2 (pt) uso de masitinibe para tratamento de uma subpopulação de pacientes com esclerose lateral amiotrófica
IL280475A (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
MX389742B (es) Composiciones y metodos para reducir eventos adversos cardiovasculares graves.
BR112017006406A2 (pt) composições e métodos para o tratamento e profilaxia de infecções de sítio cirúrgico
BR112018017233A2 (pt) uso de i. butyriciproducens e/ou e. hallii, e, composição
IL289943A (en) Medicinal and/or pharmaceutical compositions for insertion into a blister, preparation and uses
CL2016002151A1 (es) Derivados de piridazina para uso en la prevención o el tratamiento de un trastorno atáxico
IL285921A (en) Istaroxime-containing intravenous formulation for the treatment of acute heart failure (ahf)
BR112016029437A2 (pt) métodos para tratamento e prevenção de doenças de instabilidade vascular
CL2013001910A1 (es) Compuestos derivados de fenil-isoxazol; metodo para prepararlos; composicion farmaceutica que los comprende; combinacion que los comprende junto a otro agente terapeutico o preventivo de infecciones virales; metodo para prevenir o tratar infecciones virales; y su uso para el tratamiento de infecciones virales.
DK3615034T3 (da) Rucaparib, talazoparib, veliparib, olaparib og azd 2461 til behandling af forringet hudsårheling
CL2022001736A1 (es) Nuevos compuestos farmacéuticos